Clorox has lowered its fiscal 2026 guidance, now expecting net sales to decline about 6% and gross margin to contract, as the company faces flat net sales and higher manufacturing and logistics costs. Management’s revised outlook sharpens investor focus on whether upcoming fourth-quarter results can show progress in stabilizing margins. The lowered guidance frames a tougher near-term backdrop for the ERP benefits, innovation pipeline, and cost savings that many investors had counted on to support future earnings. Persistent cost inflation and tariff headwinds could have a larger and longer-lasting impact than expected, potentially eroding profitability and limiting the company’s flexibility to invest for growth.
The Clorox CompanyClorox cut fiscal 2026 guidance due to flat net sales, indicating weak end-customer demand.